AbbVie Inc. (ABBV)
NYSE: ABBV · IEX Real-Time Price · USD
161.24
+4.93 (3.15%)
At close: May 31, 2024, 4:05 PM
160.57
-0.67 (-0.42%)
After-hours: May 31, 2024, 7:59 PM EDT
AbbVie Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for AbbVie stock have an average target of 180.55, with a low estimate of 150 and a high estimate of 200. The average target predicts an increase of 11.98% from the current stock price of 161.24.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AbbVie stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 6 | 7 | 8 | 7 | 6 | 7 |
Hold | 8 | 7 | 7 | 3 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 17 | 17 | 18 | 13 | 11 | 12 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $200 | Buy | Initiates | $200 | +24.04% | May 17, 2024 |
Barclays | Barclays | Buy Maintains $195 → $187 | Buy | Maintains | $195 → $187 | +15.98% | Apr 29, 2024 |
BMO Capital | BMO Capital | Buy Maintains $195 → $180 | Buy | Maintains | $195 → $180 | +11.63% | Apr 29, 2024 |
Barclays | Barclays | Buy Maintains $185 → $195 | Buy | Maintains | $185 → $195 | +20.94% | Mar 27, 2024 |
Guggenheim | Guggenheim | Strong Buy Maintains $188 → $190 | Strong Buy | Maintains | $188 → $190 | +17.84% | Mar 22, 2024 |
Financial Forecast
Revenue This Year
56.33B
from 54.32B
Increased by 3.70%
Revenue Next Year
59.52B
from 56.33B
Increased by 5.68%
EPS This Year
11.47
from 2.72
Increased by 321.82%
EPS Next Year
12.29
from 11.47
Increased by 7.16%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 58.6B | 63.9B | 69.0B | 74.0B | 78.4B |
Avg | 56.3B | 59.5B | 64.0B | 67.5B | 71.7B |
Low | 53.8B | 55.3B | 58.7B | 62.3B | 65.6B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 7.9% | 13.4% | 15.9% | 15.5% | 16.2% |
Avg | 3.7% | 5.7% | 7.5% | 5.4% | 6.3% |
Low | -1.0% | -1.8% | -1.4% | -2.6% | -2.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 11.97 | 13.35 | 15.11 | 16.29 | 18.09 |
Avg | 11.47 | 12.29 | 13.81 | 14.88 | 16.23 |
Low | 10.80 | 11.17 | 12.47 | 13.29 | 14.27 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 340.1% | 16.3% | 22.9% | 17.9% | 21.6% |
Avg | 321.8% | 7.2% | 12.4% | 7.7% | 9.1% |
Low | 297.0% | -2.6% | 1.4% | -3.8% | -4.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.